ASHLEY OBERMEYER: Open Payments
NPI 1063059616 · MILAN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 9 payments from 4 companies in 2025. Trend: 2023 $179 · 2024 $452 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, Kerendia, QULIPTA, UBRELVY, XIFAXAN.
Industry payments across OH — which companies pay providers there.
